5% STAKE4588.TTSECAYMAN ISLANDS

Evo Fund lowers stake in Oncolys BioPharma to 13.49%

Stake history

12%14%16%18%15.19%PriorPrior: 15.19% · prior ratio stated in S100U4FX13.49%Aug 1Aug 1: 13.49% · S100U4FX
12%14%16%18%15.19%PriorPrior: 15.19% · prior ratio stated in S100U4FX13.49%Aug 1Aug 1: 13.49% · S100U4FX

Summary

Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2024-08-01 10:59 JST concerning Oncolys BioPharma Inc. Reported holding ratio: 13.49%, previous report: 15.19%.

Open the price chart on TradingView.

Source: EDINET S100U4FX ↗ · PDL1.0 · Not investment advice